Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Contemporary Clinical Trials|March 20, 2012
A Bayesian adaptive design for multi-dose, randomized, placebo-controlled phase I/II trialsFang Xie, Yuan Ji, Lothar TremmelThe Clinical Journal of Pain|October 24, 2006
A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancerRussell K Portenoy, Donald Taylor, John Messina, et al.Pharmaceutical Medicine|April 18, 2023
Value and Implementation of the Aggregate Safety Assessment PlanBarbara A Hendrickson, Anupam Agarwal, Dimitri Bennett, et al.Contemporary Clinical Trials|May 17, 2025
A visual safety risk evaluation tool in early clinical phasesKathrin Wawra-Hehenberger, Vanessa Pencelli, January Anne Pardo, et al.Clinical Lymphoma, Myeloma & Leukemia|December 31, 2010
Bendamustine produces durable responses with an acceptable safety profile in patients with rituximab-refractory indolent non-Hodgkin lymphomaBruce D Cheson, Jonathan W Friedberg, Brad S Kahl, et al.Pharmaceutical Medicine|July 3, 2022
Global Landscape of Benefit-Risk Considerations for Medicinal Products: Current State and Future DirectionsMax Waschbusch, Lisa Rodriguez, Andreas Brueckner, et al.Plos One|August 5, 2025
Cerebrospinal fluid haptoglobin levels and outcome after aneurysmal subarachnoid haemorrhage: Evidence from Mendelian randomizationGbenga A Kayode, Loukas Zagkos, Godspower Oboli, et al.Therapeutic Innovation & Regulatory Science|March 23, 2021
Aggregate Safety Assessment Planning for the Drug Development Life-CycleBarbara A Hendrickson, William Wang, Greg Ball, et al.Therapeutic Innovation & Regulatory Science|February 20, 2020
Global Regulatory Landscape for Aggregate Safety Assessments: Recent Developments and Future DirectionsGreg Ball, Raffael Kurek, Barbara A Hendrickson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2009
Phase III randomized study of bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukemiaWolfgang U Knauf, Toshko Lissichkov, Ali Aldaoud, et al.Pageof 2